<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo</dc:title>
  <dc:creator>Konou, A. A.</dc:creator>
  <dc:creator>Salou, M.</dc:creator>
  <dc:creator>/Vidal, Nicole</dc:creator>
  <dc:creator>Kodah, P.</dc:creator>
  <dc:creator>Kombate, D.</dc:creator>
  <dc:creator>Kpanla, P.</dc:creator>
  <dc:creator>Nabroulaba, T.</dc:creator>
  <dc:creator>Nyametso, D.</dc:creator>
  <dc:creator>Singo-Tokofai, A.</dc:creator>
  <dc:creator>Pitche, P.</dc:creator>
  <dc:creator>Delaporte, Eric</dc:creator>
  <dc:creator>Prince-David, M.</dc:creator>
  <dc:creator>/Peeters, Martine</dc:creator>
  <dc:creator>Dagnra, A. Y.</dc:creator>
  <dc:subject>HIV</dc:subject>
  <dc:subject>Antiretroviral treatment</dc:subject>
  <dc:subject>Drug resistance</dc:subject>
  <dc:subject>Semi-rural</dc:subject>
  <dc:subject>Public health</dc:subject>
  <dc:subject>Togo</dc:subject>
  <dc:subject>Africa</dc:subject>
  <dc:description>Background: Access to antiretroviral treatment (ART) in resource-limited countries has increased significantly but scaling-up ART into semi-rural and rural areas is more recent. Information on treatment outcome in such areas is still very limited notably due to additional difficulties to manage ART in these areas. Results: 387 HIV-1 infected adults (&gt;= 18 years) were consecutively enrolled when attending healthcare services for their routine medical visit at 12 or 24 months on first-line ART in five HIV care centers (four semi-rural and one rural). Among them, 102 patients were on first-line ART for 12 +/- 2 months (M12) and 285 for 24 +/- 2 months (M24). Virological failure was observed in 70 (18.1 %) patients ranging from 13.9 to 31.6 % at M12 and from 8.1 to 22.4 % at M24 across the different sites. For 67/70 patients, sequencing was successful and drug resistance mutations were observed in 65 (97 %). The global prevalence of drug resistance in the study population was thus at least 16.8 % (65/387). Moreover, 32 (8.3 %) and 27 (6.9 %) patients were either on a completely ineffective ART regime or with only a single drug active. Several patients accumulated high numbers of mutations and developed also cross-resistance to abacavir, didanosine or the new NNRTI drugs like etravirine and rilpivirine. Conclusion: The observations on ART treatment outcome from ART clinics in semi-rural areas are close to previous observations in Lom the capital city suggesting that national ART-programme management plays a role in treatment outcome.</dc:description>
  <dc:date>2015</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010065519</dc:identifier>
  <dc:identifier>fdi:010065519</dc:identifier>
  <dc:identifier>Konou A. A., Salou M., Vidal Nicole, Kodah P., Kombate D., Kpanla P., Nabroulaba T., Nyametso D., Singo-Tokofai A., Pitche P., Delaporte Eric, Prince-David M., Peeters Martine, Dagnra A. Y.. Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo. 2015, 12, 38 [8 ]</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>TOGO</dc:coverage>
</oai_dc:dc>
